نتائج البحث - "Haruki Kobayashi"

1

Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study

المصدر: European Journal of Cancer. 145:183-193

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Alectinib, Oncology, endocrine system, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Time Factors, Population, Carbazoles, 03 medical and health sciences, 0302 clinical medicine, Crizotinib, Japan, Piperidines, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Medicine, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, education, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Gene Rearrangement, education.field_of_study, business.industry, Hazard ratio, Retrospective cohort study, Middle Aged, respiratory system, medicine.disease, Progression-Free Survival, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Non small cell, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e9265c8c617b9713445e15c43517bfTest
https://doi.org/10.1016/j.ejca.2020.12.026Test

2

Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy

المؤلفون: Hiroaki Kodama, Tateaki Naito, Hirotsugu Kenmotsu, Hideyuki Harada, Shota Omori, Kazushige Wakuda, Toshiaki Takahashi, Michitoshi Yabe, Haruki Kobayashi, Koji Muramatsu, Tetsuo Shimizu, Akira Ono, Nobuaki Mamesaya, Taichi Miyawaki, Eriko Miyawaki, Yasuhiro Gon, Naoya Nishioka, Takashi Sugino, Haruyasu Murakami

المصدر: International Journal of Clinical Oncology. 26:659-669

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c975ec864ca94bc4feff7af6b7799cTest
https://doi.org/10.1007/s10147-020-01856-xTest

3

Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression

المؤلفون: Michitoshi Yabe, Haruyasu Murakami, Takahisa Kawamura, Taichi Miyawaki, Tateaki Naito, Eriko Miyawaki, Toshiaki Takahashi, Hirotsugu Kenmotsu, Hideyuki Harada, Kazushige Wakuda, Naoya Nishioka, Akira Ono, Masahiro Endo, Nobuaki Mamesaya, Shota Omori, Haruki Kobayashi, Hiroaki Kodama, Yasuhiro Gon

المصدر: Lung Cancer. 151:60-68

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ad7ba3e9b345637d5e3131f845ae36Test
https://doi.org/10.1016/j.lungcan.2020.11.009Test

4

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer

المؤلفون: Taichi Miyawaki, Eriko Miyawaki, Tateaki Naito, Naoya Nishioka, Hiroaki Kodama, Kazushige Wakuda, Haruyasu Murakami, Nobuaki Mamesaya, Koichi Takayama, Shota Omori, Akira Ono, Hirotsugu Kenmotsu, Haruki Kobayashi, Toshiaki Takahashi, Keita Mori, Akifumi Notsu

المصدر: Cancer Medicine

مصطلحات موضوعية: 0301 basic medicine, non‐small cell lung cancer, Adult, Male, Cancer Research, medicine.medical_specialty, muscle quantity, Lung Neoplasms, Time Factors, medicine.medical_treatment, Urology, muscle quality, 03 medical and health sciences, 0302 clinical medicine, Lumbar, PD‐1/PD‐L1 inhibitor, Hounsfield scale, myosteatosis, Carcinoma, Non-Small-Cell Lung, Medicine, Humans, Radiology, Nuclear Medicine and imaging, Lung cancer, Muscle, Skeletal, Immune Checkpoint Inhibitors, Original Research, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Therapeutic effect, Skeletal muscle, Clinical Cancer Research, Immunotherapy, Middle Aged, medicine.disease, Progression-Free Survival, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Body Composition, Female, Non small cell, business, Tomography, X-Ray Computed, Body mass index

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9abfd75522ced60911eeca154a6d003bTest
http://europepmc.org/articles/PMC7826480Test

5

A BLUS1 kinase signal and a decrease in intercellular CO(2) concentration are necessary for stomatal opening in response to blue light

المؤلفون: Ken-ichiro Shimazaki, Shota Yamauchi, Sakurako Hosotani, Atsushi Takemiya, Haruki Kobayashi, Shigekazu Koya, Saashia Fuji

المصدر: Plant Cell

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5248e8aac804837a7636c51e022e5fc0Test
https://europepmc.org/articles/PMC8254492Test/

6

Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation

المؤلفون: Hirotsugu Kenmotsu, Haruyasu Murakami, Tateaki Naito, Takahisa Kawamura, Shota Omori, Keita Mori, Kazushige Wakuda, Haruki Kobayashi, Kazuhisa Nakashima, Akira Ono, Toshiaki Takahashi, Masahiro Endo

المصدر: Investigational New Drugs

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Lung Neoplasms, 0302 clinical medicine, Non-small cell lung cancer, Malignant effusion, Epidermal growth factor, Carcinoma, Non-Small-Cell Lung, Pharmacology (medical), Osimertinib, Aged, 80 and over, Aniline Compounds, Middle Aged, Prognosis, ErbB Receptors, Survival Rate, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, Short Report, Antineoplastic Agents, 03 medical and health sciences, EGFR-TKI, Internal medicine, medicine, Humans, Lung cancer, Aged, Retrospective Studies, Pharmacology, Acrylamides, Lung, business.industry, medicine.disease, Confidence interval, Pleural Effusion, Malignant, respiratory tract diseases, 030104 developmental biology, Drug Resistance, Neoplasm, Egfr mutation, Mutation, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bc8bb2c0ffe3932f6105917cbca7c8Test
https://doi.org/10.1007/s10637-019-00808-1Test

7

Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer

المؤلفون: Hirotsugu Kenmotsu, Tateaki Naito, Takashi Nakajima, Haruyasu Murakami, Shota Omori, Haruki Kobayashi, Kazuhisa Nakashima, Toshiaki Takahashi, Akira Ono, Masahiro Endo, Kazushige Wakuda

المصدر: Japanese Journal of Clinical Oncology. 48:822-826

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Antineoplastic Agents, Kaplan-Meier Estimate, Neutropenia, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, Anthracyclines, Radiology, Nuclear Medicine and imaging, Lung cancer, Adverse effect, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, Leukopenia, business.industry, General Medicine, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, Chemotherapy regimen, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, medicine.symptom, business, Amrubicin, Febrile neutropenia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f570bd17a82046e73493b07f9ada82efTest
https://doi.org/10.1093/jjco/hyy107Test

8

Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma

المؤلفون: Naoya Nishioka, Kazushige Wakuda, Taichi Miyawaki, Tateaki Naito, Eriko Miyawaki, Michitoshi Yabe, Akira Ono, Masahiro Endo, Toshiaki Takahashi, Shota Omori, Haruyasu Murakami, Haruki Kobayashi, Takahisa Kawamura, Hirotsugu Kenmotsu, Hiroaki Kodama, Nobuaki Mamesaya

المصدر: Investigational new drugs. 39(2)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Antineoplastic Agents, behavioral disciplines and activities, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Carcinoma, Humans, Pharmacology (medical), Osimertinib, Adverse effect, Aged, Retrospective Studies, Pharmacology, Aged, 80 and over, Acrylamides, Aniline Compounds, business.industry, Interstitial lung disease, Cancer, Retrospective cohort study, respiratory system, Middle Aged, medicine.disease, respiratory tract diseases, Discontinuation, body regions, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Lung Diseases, Interstitial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75ad6be975b9d74603b9a46914901ce1Test
https://pubmed.ncbi.nlm.nih.gov/32955628Test

9

Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy

المؤلفون: Kazushige Wakuda, Hirotsugu Kenmotsu, Keita Mori, Kazuhisa Takahashi, Taichi Miyawaki, Akifumi Notsu, Tateaki Naito, Yasuhisa Ohde, Hideyuki Harada, Haruyasu Murakami, Shota Omori, Haruki Kobayashi, Akira Ono, Nobuaki Mamesaya, Eriko Miyawaki, Masahiro Endo, Toshiaki Takahashi

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, non–small‐cell lung cancer, oligometastatic disease, Systemic therapy, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Clinical Research, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Neoplasm Metastasis, Lung cancer, threshold number of metastases, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Receiver operating characteristic, business.industry, pattern of progressive disease, Hazard ratio, Area under the curve, Retrospective cohort study, General Medicine, Odds ratio, Middle Aged, medicine.disease, respiratory tract diseases, platinum‐based chemotherapy, 030104 developmental biology, 030220 oncology & carcinogenesis, Disease Progression, Female, Original Article, Neoplasm Recurrence, Local, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51912a77c282eb3313ab48292ab44654Test
https://pubmed.ncbi.nlm.nih.gov/33098119Test

10

PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer

المؤلفون: Nobuaki Mamesaya, Tateaki Naito, Kazushige Wakuda, Toshiaki Takahashi, Akira Ono, Haruyasu Murakami, Shota Omori, Takahisa Kawamura, Eriko Miyawaki, Haruki Kobayashi, Hirotsugu Kenmotsu, Keita Mori

المصدر: Japanese journal of clinical oncology. 50(5)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Mutant, Pembrolizumab, EGFR Gene Mutation, medicine.disease_cause, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Medicine, Humans, Radiology, Nuclear Medicine and imaging, In patient, Epidermal growth factor receptor, Lung cancer, Aged, Retrospective Studies, Mutation, biology, business.industry, General Medicine, Middle Aged, medicine.disease, ErbB Receptors, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, biology.protein, Female, Non small cell, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7d030f38c89bc672a655aa2df60972Test
https://pubmed.ncbi.nlm.nih.gov/32211792Test

تنقيح النتائج